Antral Follicle Count versus Basal Follicle Stimulating Hormone as Predictors of Ovarian Response in Women Undergoing Superovulation with Long Protocol for Assisted Reproduction

Relation between Anti-Müllerian Hormone with Antral Follicle Count and Ovarian Volume in Polycystic Ovary Syndrome

Usefulness of Measuring Serum LH Concentration on Day 1 Before Ovarian Stimulation in Non- Obese Polycystic Cases

PREDICTIVE VALUE OF FOLLICULAR FLUID GHRELIN IN WOMEN WITH POLYCYSTIC OVARIAN DISEASE WHO UNDERGO INTRACYTOPLASMIC SPERM INJECTION

Serum Anti-Mullerian Hormone, Follicle Stimulating Hormone and Antral Follicle Count Measurement as a Prediction for Pregnancy Rates in IVF/ICSI cycle

SERUM ANTI- MULLERIAN HORMONE IS A BETTER PREDICTOR OF OVARIAN RESERVE AT THE EARLY FOLLICULAR PHASE.

Using Anti-Müllerian Hormone and Serum Estradiol to Predict Ovarian Hyperstimulation Syndrome in Patients Using Antagonist Protocol During IVF/ICSI Cycles

Anti-Mullerian Hormone Serum Concentrationsin Women with Polycystic Ovaries and Normoovulatory Women of Reproductive Age

Anti-Müllerian hormone for prediction of ovarian stimulation response in polycystic ovary syndrome

Ovarian Reserve Assessment after Laparoscopic Ovarian Drilling in women with Polycystic Ovary Syndrome